nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—AKR1C3—prostate cancer	0.361	0.851	CbGaD
Meclofenamic acid—SLCO1C1—Conjugated Estrogens—prostate cancer	0.111	0.326	CbGbCtD
Meclofenamic acid—SLCO1C1—Estradiol—prostate cancer	0.097	0.286	CbGbCtD
Meclofenamic acid—AKR1C3—Doxorubicin—prostate cancer	0.0752	0.222	CbGbCtD
Meclofenamic acid—PTGS2—prostate cancer	0.0633	0.149	CbGaD
Meclofenamic acid—SLC22A6—Conjugated Estrogens—prostate cancer	0.0231	0.0682	CbGbCtD
Meclofenamic acid—PTGS2—Etoposide—prostate cancer	0.0179	0.0528	CbGbCtD
Meclofenamic acid—PTGS1—Etoposide—prostate cancer	0.0151	0.0446	CbGbCtD
Meclofenamic acid—AKR1C3—Podofilox—Etoposide—prostate cancer	0.00191	1	CbGdCrCtD
Meclofenamic acid—AKR1C3—prostate gland—prostate cancer	0.00171	0.0856	CbGeAlD
Meclofenamic acid—ALOX5—prostate gland—prostate cancer	0.00151	0.0755	CbGeAlD
Meclofenamic acid—AKR1C3—seminal vesicle—prostate cancer	0.00145	0.0724	CbGeAlD
Meclofenamic acid—Niclosamide—STAT3—prostate cancer	0.00133	0.332	CrCbGaD
Meclofenamic acid—SLCO1C1—renal system—prostate cancer	0.00127	0.0635	CbGeAlD
Meclofenamic acid—KCNQ2—testis—prostate cancer	0.00118	0.059	CbGeAlD
Meclofenamic acid—AKR1C3—urethra—prostate cancer	0.00115	0.0573	CbGeAlD
Meclofenamic acid—ALOX5—urethra—prostate cancer	0.00101	0.0505	CbGeAlD
Meclofenamic acid—AKR1C3—bone marrow—prostate cancer	0.000882	0.0441	CbGeAlD
Meclofenamic acid—SLCO1C1—testis—prostate cancer	0.00082	0.041	CbGeAlD
Meclofenamic acid—ALOX5—bone marrow—prostate cancer	0.000777	0.0389	CbGeAlD
Meclofenamic acid—AKR1C3—testis—prostate cancer	0.000754	0.0377	CbGeAlD
Meclofenamic acid—ALOX5—testis—prostate cancer	0.000664	0.0332	CbGeAlD
Meclofenamic acid—PTGS1—prostate gland—prostate cancer	0.000605	0.0303	CbGeAlD
Meclofenamic acid—SLCO1C1—lymph node—prostate cancer	0.000595	0.0298	CbGeAlD
Meclofenamic acid—PTGS2—prostate gland—prostate cancer	0.000579	0.029	CbGeAlD
Meclofenamic acid—AKR1C3—lymph node—prostate cancer	0.000546	0.0273	CbGeAlD
Meclofenamic acid—PTGS1—seminal vesicle—prostate cancer	0.000512	0.0256	CbGeAlD
Meclofenamic acid—Mefenamic acid—AKR1C3—prostate cancer	0.000498	0.124	CrCbGaD
Meclofenamic acid—PTGS2—seminal vesicle—prostate cancer	0.000489	0.0245	CbGeAlD
Meclofenamic acid—ALOX5—lymph node—prostate cancer	0.000482	0.0241	CbGeAlD
Meclofenamic acid—PTGS1—epithelium—prostate cancer	0.000445	0.0223	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—TP53—prostate cancer	0.000435	0.109	CrCbGaD
Meclofenamic acid—PTGS2—epithelium—prostate cancer	0.000425	0.0213	CbGeAlD
Meclofenamic acid—PTGS1—renal system—prostate cancer	0.000413	0.0206	CbGeAlD
Meclofenamic acid—PTGS2—renal system—prostate cancer	0.000394	0.0197	CbGeAlD
Meclofenamic acid—PTGS2—urethra—prostate cancer	0.000387	0.0194	CbGeAlD
Meclofenamic acid—PTGS2—bone marrow—prostate cancer	0.000298	0.0149	CbGeAlD
Meclofenamic acid—PTGS1—testis—prostate cancer	0.000267	0.0133	CbGeAlD
Meclofenamic acid—Lumiracoxib—CYP2C19—prostate cancer	0.000231	0.0578	CrCbGaD
Meclofenamic acid—Diclofenac—CYP2C18—prostate cancer	0.000225	0.0561	CrCbGaD
Meclofenamic acid—Diclofenac—CXCL8—prostate cancer	0.000215	0.0537	CrCbGaD
Meclofenamic acid—PTGS1—lymph node—prostate cancer	0.000193	0.00967	CbGeAlD
Meclofenamic acid—PTGS2—lymph node—prostate cancer	0.000185	0.00925	CbGeAlD
Meclofenamic acid—Insomnia—Conjugated Estrogens—prostate cancer	0.000165	0.0015	CcSEcCtD
Meclofenamic acid—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000163	0.00149	CcSEcCtD
Meclofenamic acid—Malaise—Estradiol—prostate cancer	0.000161	0.00147	CcSEcCtD
Meclofenamic acid—Asthenia—Ethinyl Estradiol—prostate cancer	0.00016	0.00146	CcSEcCtD
Meclofenamic acid—Decreased appetite—Goserelin—prostate cancer	0.00016	0.00146	CcSEcCtD
Meclofenamic acid—Fatigue—Goserelin—prostate cancer	0.000158	0.00144	CcSEcCtD
Meclofenamic acid—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000158	0.00144	CcSEcCtD
Meclofenamic acid—Pruritus—Ethinyl Estradiol—prostate cancer	0.000158	0.00144	CcSEcCtD
Meclofenamic acid—Palpitations—Estradiol—prostate cancer	0.000158	0.00144	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—prostate cancer	0.000158	0.00144	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000157	0.00143	CcSEcCtD
Meclofenamic acid—Constipation—Goserelin—prostate cancer	0.000157	0.00143	CcSEcCtD
Meclofenamic acid—Fatigue—Conjugated Estrogens—prostate cancer	0.000157	0.00143	CcSEcCtD
Meclofenamic acid—Nausea—Bicalutamide—prostate cancer	0.000157	0.00143	CcSEcCtD
Meclofenamic acid—Vision blurred—Mitoxantrone—prostate cancer	0.000157	0.00143	CcSEcCtD
Meclofenamic acid—Constipation—Conjugated Estrogens—prostate cancer	0.000156	0.00142	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000154	0.00141	CcSEcCtD
Meclofenamic acid—Neutropenia—Docetaxel—prostate cancer	0.000154	0.00141	CcSEcCtD
Meclofenamic acid—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000153	0.00139	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Goserelin—prostate cancer	0.000151	0.00138	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Goserelin—prostate cancer	0.00015	0.00137	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Etoposide—prostate cancer	0.00015	0.00137	CcSEcCtD
Meclofenamic acid—Discomfort—Estradiol—prostate cancer	0.00015	0.00137	CcSEcCtD
Meclofenamic acid—Malaise—Mitoxantrone—prostate cancer	0.00015	0.00137	CcSEcCtD
Meclofenamic acid—Neutropenia—Capecitabine—prostate cancer	0.000149	0.00136	CcSEcCtD
Meclofenamic acid—Leukopenia—Mitoxantrone—prostate cancer	0.000149	0.00136	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000149	0.00136	CcSEcCtD
Meclofenamic acid—Urticaria—Goserelin—prostate cancer	0.000146	0.00133	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000146	0.00133	CcSEcCtD
Meclofenamic acid—Oedema—Estradiol—prostate cancer	0.000146	0.00133	CcSEcCtD
Meclofenamic acid—Abdominal pain—Goserelin—prostate cancer	0.000145	0.00132	CcSEcCtD
Meclofenamic acid—Renal failure—Docetaxel—prostate cancer	0.000145	0.00132	CcSEcCtD
Meclofenamic acid—Urticaria—Conjugated Estrogens—prostate cancer	0.000145	0.00132	CcSEcCtD
Meclofenamic acid—Lumiracoxib—PTGS2—prostate cancer	0.000144	0.036	CrCbGaD
Meclofenamic acid—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000144	0.00131	CcSEcCtD
Meclofenamic acid—Stomatitis—Docetaxel—prostate cancer	0.000143	0.00131	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Docetaxel—prostate cancer	0.000143	0.0013	CcSEcCtD
Meclofenamic acid—Vomiting—Ethinyl Estradiol—prostate cancer	0.000142	0.00129	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000141	0.00129	CcSEcCtD
Meclofenamic acid—Alopecia—Etoposide—prostate cancer	0.00014	0.00128	CcSEcCtD
Meclofenamic acid—Renal failure—Capecitabine—prostate cancer	0.00014	0.00128	CcSEcCtD
Meclofenamic acid—Discomfort—Mitoxantrone—prostate cancer	0.00014	0.00128	CcSEcCtD
Meclofenamic acid—Stomatitis—Capecitabine—prostate cancer	0.000139	0.00127	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Capecitabine—prostate cancer	0.000138	0.00126	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Docetaxel—prostate cancer	0.000137	0.00125	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—CYP2C19—prostate cancer	0.000137	0.0341	CrCbGaD
Meclofenamic acid—Dermatitis exfoliative—Epirubicin—prostate cancer	0.000136	0.00124	CcSEcCtD
Meclofenamic acid—Oedema—Mitoxantrone—prostate cancer	0.000136	0.00124	CcSEcCtD
Meclofenamic acid—Neutropenia—Prednisone—prostate cancer	0.000133	0.00121	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Capecitabine—prostate cancer	0.000133	0.00121	CcSEcCtD
Meclofenamic acid—Haemoglobin—Docetaxel—prostate cancer	0.000133	0.00121	CcSEcCtD
Meclofenamic acid—Nausea—Ethinyl Estradiol—prostate cancer	0.000133	0.00121	CcSEcCtD
Meclofenamic acid—Haemorrhage—Docetaxel—prostate cancer	0.000132	0.0012	CcSEcCtD
Meclofenamic acid—Asthenia—Goserelin—prostate cancer	0.000132	0.0012	CcSEcCtD
Meclofenamic acid—Insomnia—Estradiol—prostate cancer	0.000132	0.0012	CcSEcCtD
Meclofenamic acid—Paraesthesia—Estradiol—prostate cancer	0.000131	0.00119	CcSEcCtD
Meclofenamic acid—Asthenia—Conjugated Estrogens—prostate cancer	0.000131	0.00119	CcSEcCtD
Meclofenamic acid—Pruritus—Goserelin—prostate cancer	0.00013	0.00119	CcSEcCtD
Meclofenamic acid—Anorexia—Mitoxantrone—prostate cancer	0.000129	0.00118	CcSEcCtD
Meclofenamic acid—Pruritus—Conjugated Estrogens—prostate cancer	0.000129	0.00117	CcSEcCtD
Meclofenamic acid—Haemoglobin—Capecitabine—prostate cancer	0.000128	0.00117	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Etoposide—prostate cancer	0.000128	0.00117	CcSEcCtD
Meclofenamic acid—Haemorrhage—Capecitabine—prostate cancer	0.000128	0.00117	CcSEcCtD
Meclofenamic acid—Decreased appetite—Estradiol—prostate cancer	0.000127	0.00115	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000126	0.00115	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Estradiol—prostate cancer	0.000126	0.00115	CcSEcCtD
Meclofenamic acid—Diarrhoea—Goserelin—prostate cancer	0.000126	0.00115	CcSEcCtD
Meclofenamic acid—Fatigue—Estradiol—prostate cancer	0.000126	0.00114	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Docetaxel—prostate cancer	0.000125	0.00114	CcSEcCtD
Meclofenamic acid—Malaise—Etoposide—prostate cancer	0.000125	0.00114	CcSEcCtD
Meclofenamic acid—Constipation—Estradiol—prostate cancer	0.000125	0.00114	CcSEcCtD
Meclofenamic acid—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000124	0.00114	CcSEcCtD
Meclofenamic acid—Leukopenia—Etoposide—prostate cancer	0.000124	0.00113	CcSEcCtD
Meclofenamic acid—Paraesthesia—Mitoxantrone—prostate cancer	0.000122	0.00111	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Capecitabine—prostate cancer	0.000121	0.0011	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Estradiol—prostate cancer	0.00012	0.00109	CcSEcCtD
Meclofenamic acid—Tinnitus—Capecitabine—prostate cancer	0.000119	0.00109	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Estradiol—prostate cancer	0.000119	0.00109	CcSEcCtD
Meclofenamic acid—Decreased appetite—Mitoxantrone—prostate cancer	0.000118	0.00108	CcSEcCtD
Meclofenamic acid—Fatigue—Mitoxantrone—prostate cancer	0.000117	0.00107	CcSEcCtD
Meclofenamic acid—Vomiting—Goserelin—prostate cancer	0.000117	0.00107	CcSEcCtD
Meclofenamic acid—Alopecia—Docetaxel—prostate cancer	0.000117	0.00106	CcSEcCtD
Meclofenamic acid—Discomfort—Etoposide—prostate cancer	0.000116	0.00106	CcSEcCtD
Meclofenamic acid—Constipation—Mitoxantrone—prostate cancer	0.000116	0.00106	CcSEcCtD
Meclofenamic acid—Vomiting—Conjugated Estrogens—prostate cancer	0.000116	0.00106	CcSEcCtD
Meclofenamic acid—Urticaria—Estradiol—prostate cancer	0.000116	0.00106	CcSEcCtD
Meclofenamic acid—Abdominal pain—Estradiol—prostate cancer	0.000115	0.00105	CcSEcCtD
Meclofenamic acid—Haemoglobin—Prednisone—prostate cancer	0.000114	0.00104	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—prostate cancer	0.000114	0.0285	CrCbGaD
Meclofenamic acid—Haemorrhage—Prednisone—prostate cancer	0.000114	0.00104	CcSEcCtD
Meclofenamic acid—Alopecia—Capecitabine—prostate cancer	0.000113	0.00103	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Mitoxantrone—prostate cancer	0.000112	0.00102	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000111	0.00101	CcSEcCtD
Meclofenamic acid—Eosinophilia—Epirubicin—prostate cancer	0.00011	0.001	CcSEcCtD
Meclofenamic acid—Nausea—Goserelin—prostate cancer	0.000109	0.000995	CcSEcCtD
Meclofenamic acid—Nausea—Conjugated Estrogens—prostate cancer	0.000108	0.000986	CcSEcCtD
Meclofenamic acid—Urticaria—Mitoxantrone—prostate cancer	0.000108	0.000983	CcSEcCtD
Meclofenamic acid—Anorexia—Etoposide—prostate cancer	0.000108	0.000981	CcSEcCtD
Meclofenamic acid—Abdominal pain—Mitoxantrone—prostate cancer	0.000107	0.000978	CcSEcCtD
Meclofenamic acid—Vision blurred—Capecitabine—prostate cancer	0.000105	0.000956	CcSEcCtD
Meclofenamic acid—Asthenia—Estradiol—prostate cancer	0.000104	0.000953	CcSEcCtD
Meclofenamic acid—Neutropenia—Epirubicin—prostate cancer	0.000104	0.000949	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Capecitabine—prostate cancer	0.000103	0.000942	CcSEcCtD
Meclofenamic acid—Pruritus—Estradiol—prostate cancer	0.000103	0.00094	CcSEcCtD
Meclofenamic acid—Leukopenia—Docetaxel—prostate cancer	0.000103	0.000938	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—prostate cancer	0.000102	0.000929	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP2E1—prostate cancer	0.000102	0.0254	CrCbGaD
Meclofenamic acid—Palpitations—Docetaxel—prostate cancer	0.000102	0.000926	CcSEcCtD
Meclofenamic acid—Paraesthesia—Etoposide—prostate cancer	0.000101	0.000924	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP2C19—prostate cancer	0.000101	0.0252	CrCbGaD
Meclofenamic acid—Alopecia—Prednisone—prostate cancer	0.000101	0.000918	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP1A1—prostate cancer	0.0001	0.0251	CrCbGaD
Meclofenamic acid—Malaise—Capecitabine—prostate cancer	0.0001	0.000915	CcSEcCtD
Meclofenamic acid—Diarrhoea—Estradiol—prostate cancer	9.96e-05	0.000909	CcSEcCtD
Meclofenamic acid—Leukopenia—Capecitabine—prostate cancer	9.96e-05	0.000908	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—prostate cancer	9.83e-05	0.000897	CcSEcCtD
Meclofenamic acid—Palpitations—Capecitabine—prostate cancer	9.83e-05	0.000897	CcSEcCtD
Meclofenamic acid—Decreased appetite—Etoposide—prostate cancer	9.81e-05	0.000895	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—prostate cancer	9.75e-05	0.000889	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Etoposide—prostate cancer	9.74e-05	0.000889	CcSEcCtD
Meclofenamic acid—Asthenia—Mitoxantrone—prostate cancer	9.73e-05	0.000888	CcSEcCtD
Meclofenamic acid—Fatigue—Etoposide—prostate cancer	9.73e-05	0.000887	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—prostate cancer	9.67e-05	0.000882	CcSEcCtD
Meclofenamic acid—Constipation—Etoposide—prostate cancer	9.65e-05	0.00088	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—prostate cancer	9.64e-05	0.000879	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—prostate cancer	9.63e-05	0.000878	CcSEcCtD
Meclofenamic acid—Oedema—Docetaxel—prostate cancer	9.38e-05	0.000855	CcSEcCtD
Meclofenamic acid—Discomfort—Capecitabine—prostate cancer	9.36e-05	0.000854	CcSEcCtD
Meclofenamic acid—Vision blurred—Prednisone—prostate cancer	9.34e-05	0.000852	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Etoposide—prostate cancer	9.3e-05	0.000848	CcSEcCtD
Meclofenamic acid—Diarrhoea—Mitoxantrone—prostate cancer	9.28e-05	0.000847	CcSEcCtD
Meclofenamic acid—Vomiting—Estradiol—prostate cancer	9.26e-05	0.000844	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—prostate cancer	9.26e-05	0.000844	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Etoposide—prostate cancer	9.23e-05	0.000842	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Prednisone—prostate cancer	9.2e-05	0.000839	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	9.1e-05	0.00083	CcSEcCtD
Meclofenamic acid—Oedema—Capecitabine—prostate cancer	9.08e-05	0.000828	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—prostate cancer	9.02e-05	0.000823	CcSEcCtD
Meclofenamic acid—Urticaria—Etoposide—prostate cancer	8.97e-05	0.000818	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—prostate cancer	8.95e-05	0.000816	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—prostate cancer	8.95e-05	0.000816	CcSEcCtD
Meclofenamic acid—Anorexia—Docetaxel—prostate cancer	8.94e-05	0.000815	CcSEcCtD
Meclofenamic acid—Malaise—Prednisone—prostate cancer	8.94e-05	0.000815	CcSEcCtD
Meclofenamic acid—Abdominal pain—Etoposide—prostate cancer	8.92e-05	0.000814	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—prostate cancer	8.92e-05	0.000814	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—prostate cancer	8.9e-05	0.000812	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—prostate cancer	8.73e-05	0.0218	CrCbGaD
Meclofenamic acid—Anorexia—Capecitabine—prostate cancer	8.66e-05	0.000789	CcSEcCtD
Meclofenamic acid—Nausea—Estradiol—prostate cancer	8.65e-05	0.000789	CcSEcCtD
Meclofenamic acid—Vomiting—Mitoxantrone—prostate cancer	8.63e-05	0.000787	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Doxorubicin—prostate cancer	8.56e-05	0.000781	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—prostate cancer	8.51e-05	0.0213	CrCbGaD
Meclofenamic acid—Insomnia—Docetaxel—prostate cancer	8.48e-05	0.000774	CcSEcCtD
Meclofenamic acid—Paraesthesia—Docetaxel—prostate cancer	8.42e-05	0.000768	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—prostate cancer	8.42e-05	0.000768	CcSEcCtD
Meclofenamic acid—Discomfort—Prednisone—prostate cancer	8.34e-05	0.00076	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—prostate cancer	8.3e-05	0.000757	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—prostate cancer	8.28e-05	0.000755	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—prostate cancer	8.24e-05	0.000751	CcSEcCtD
Meclofenamic acid—Insomnia—Capecitabine—prostate cancer	8.21e-05	0.000749	CcSEcCtD
Meclofenamic acid—Paraesthesia—Capecitabine—prostate cancer	8.15e-05	0.000744	CcSEcCtD
Meclofenamic acid—Decreased appetite—Docetaxel—prostate cancer	8.15e-05	0.000744	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Docetaxel—prostate cancer	8.1e-05	0.000738	CcSEcCtD
Meclofenamic acid—Asthenia—Etoposide—prostate cancer	8.1e-05	0.000738	CcSEcCtD
Meclofenamic acid—Oedema—Prednisone—prostate cancer	8.09e-05	0.000738	CcSEcCtD
Meclofenamic acid—Fatigue—Docetaxel—prostate cancer	8.09e-05	0.000737	CcSEcCtD
Meclofenamic acid—Nausea—Mitoxantrone—prostate cancer	8.06e-05	0.000735	CcSEcCtD
Meclofenamic acid—Constipation—Docetaxel—prostate cancer	8.02e-05	0.000731	CcSEcCtD
Meclofenamic acid—Pruritus—Etoposide—prostate cancer	7.98e-05	0.000728	CcSEcCtD
Meclofenamic acid—Decreased appetite—Capecitabine—prostate cancer	7.89e-05	0.00072	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—prostate cancer	7.87e-05	0.000718	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Capecitabine—prostate cancer	7.84e-05	0.000715	CcSEcCtD
Meclofenamic acid—Fatigue—Capecitabine—prostate cancer	7.83e-05	0.000714	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—prostate cancer	7.79e-05	0.00071	CcSEcCtD
Meclofenamic acid—Constipation—Capecitabine—prostate cancer	7.77e-05	0.000708	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Docetaxel—prostate cancer	7.73e-05	0.000705	CcSEcCtD
Meclofenamic acid—Diarrhoea—Etoposide—prostate cancer	7.72e-05	0.000704	CcSEcCtD
Meclofenamic acid—Anorexia—Prednisone—prostate cancer	7.71e-05	0.000703	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—prostate cancer	7.68e-05	0.000701	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Docetaxel—prostate cancer	7.67e-05	0.000699	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Capecitabine—prostate cancer	7.48e-05	0.000682	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Capecitabine—prostate cancer	7.43e-05	0.000677	CcSEcCtD
Meclofenamic acid—Abdominal pain—Docetaxel—prostate cancer	7.41e-05	0.000676	CcSEcCtD
Meclofenamic acid—Insomnia—Prednisone—prostate cancer	7.32e-05	0.000667	CcSEcCtD
Meclofenamic acid—Vision blurred—Epirubicin—prostate cancer	7.31e-05	0.000666	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—prostate cancer	7.28e-05	0.000664	CcSEcCtD
Meclofenamic acid—Paraesthesia—Prednisone—prostate cancer	7.26e-05	0.000662	CcSEcCtD
Meclofenamic acid—Urticaria—Capecitabine—prostate cancer	7.21e-05	0.000658	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—prostate cancer	7.19e-05	0.000656	CcSEcCtD
Meclofenamic acid—Abdominal pain—Capecitabine—prostate cancer	7.18e-05	0.000655	CcSEcCtD
Meclofenamic acid—Vomiting—Etoposide—prostate cancer	7.18e-05	0.000654	CcSEcCtD
Meclofenamic acid—Decreased appetite—Prednisone—prostate cancer	7.03e-05	0.000641	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS2—prostate cancer	7.01e-05	0.0175	CrCbGaD
Meclofenamic acid—Malaise—Epirubicin—prostate cancer	6.99e-05	0.000638	CcSEcCtD
Meclofenamic acid—Fatigue—Prednisone—prostate cancer	6.97e-05	0.000636	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—prostate cancer	6.94e-05	0.000633	CcSEcCtD
Meclofenamic acid—Constipation—Prednisone—prostate cancer	6.92e-05	0.000631	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—prostate cancer	6.85e-05	0.000625	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—prostate cancer	6.76e-05	0.000616	CcSEcCtD
Meclofenamic acid—Asthenia—Docetaxel—prostate cancer	6.73e-05	0.000614	CcSEcCtD
Meclofenamic acid—Nausea—Etoposide—prostate cancer	6.7e-05	0.000611	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Prednisone—prostate cancer	6.67e-05	0.000608	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—prostate cancer	6.65e-05	0.000607	CcSEcCtD
Meclofenamic acid—Pruritus—Docetaxel—prostate cancer	6.64e-05	0.000605	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Prednisone—prostate cancer	6.61e-05	0.000603	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—prostate cancer	6.52e-05	0.000595	CcSEcCtD
Meclofenamic acid—Asthenia—Capecitabine—prostate cancer	6.52e-05	0.000594	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—prostate cancer	6.47e-05	0.00059	CcSEcCtD
Meclofenamic acid—Urticaria—Prednisone—prostate cancer	6.43e-05	0.000586	CcSEcCtD
Meclofenamic acid—Pruritus—Capecitabine—prostate cancer	6.42e-05	0.000586	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—prostate cancer	6.42e-05	0.000586	CcSEcCtD
Meclofenamic acid—Diarrhoea—Docetaxel—prostate cancer	6.42e-05	0.000585	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP3A4—prostate cancer	6.41e-05	0.016	CrCbGaD
Meclofenamic acid—Abdominal pain—Prednisone—prostate cancer	6.39e-05	0.000583	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—prostate cancer	6.34e-05	0.000578	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—prostate cancer	6.33e-05	0.000577	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS2—prostate cancer	6.27e-05	0.0157	CrCbGaD
Meclofenamic acid—Diarrhoea—Capecitabine—prostate cancer	6.21e-05	0.000567	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—prostate cancer	6.03e-05	0.00055	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—prostate cancer	6.03e-05	0.00055	CcSEcCtD
Meclofenamic acid—Vomiting—Docetaxel—prostate cancer	5.96e-05	0.000544	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—prostate cancer	5.85e-05	0.000534	CcSEcCtD
Meclofenamic acid—Asthenia—Prednisone—prostate cancer	5.8e-05	0.000529	CcSEcCtD
Meclofenamic acid—Vomiting—Capecitabine—prostate cancer	5.77e-05	0.000527	CcSEcCtD
Meclofenamic acid—Pruritus—Prednisone—prostate cancer	5.72e-05	0.000522	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—prostate cancer	5.72e-05	0.000522	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—prostate cancer	5.68e-05	0.000518	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—prostate cancer	5.58e-05	0.000509	CcSEcCtD
Meclofenamic acid—Nausea—Docetaxel—prostate cancer	5.57e-05	0.000508	CcSEcCtD
Meclofenamic acid—Diarrhoea—Prednisone—prostate cancer	5.53e-05	0.000505	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—prostate cancer	5.5e-05	0.000502	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—prostate cancer	5.46e-05	0.000498	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—prostate cancer	5.45e-05	0.000497	CcSEcCtD
Meclofenamic acid—Constipation—Epirubicin—prostate cancer	5.41e-05	0.000493	CcSEcCtD
Meclofenamic acid—Nausea—Capecitabine—prostate cancer	5.39e-05	0.000492	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—prostate cancer	5.29e-05	0.000483	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—prostate cancer	5.26e-05	0.000479	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—prostate cancer	5.21e-05	0.000475	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—prostate cancer	5.17e-05	0.000472	CcSEcCtD
Meclofenamic acid—Vomiting—Prednisone—prostate cancer	5.14e-05	0.000469	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—prostate cancer	5.09e-05	0.000464	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.05e-05	0.000461	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—prostate cancer	5.05e-05	0.00046	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—prostate cancer	5.03e-05	0.000458	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—prostate cancer	5.01e-05	0.000457	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—prostate cancer	5e-05	0.000456	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—prostate cancer	4.82e-05	0.00044	CcSEcCtD
Meclofenamic acid—Nausea—Prednisone—prostate cancer	4.8e-05	0.000438	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—prostate cancer	4.79e-05	0.000437	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—prostate cancer	4.65e-05	0.000424	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—prostate cancer	4.63e-05	0.000422	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—prostate cancer	4.54e-05	0.000414	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—prostate cancer	4.48e-05	0.000408	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—prostate cancer	4.33e-05	0.000395	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—prostate cancer	4.2e-05	0.000383	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—prostate cancer	4.14e-05	0.000378	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—prostate cancer	4.02e-05	0.000367	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—prostate cancer	4e-05	0.000365	CcSEcCtD
Meclofenamic acid—Nausea—Epirubicin—prostate cancer	3.76e-05	0.000343	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—prostate cancer	3.72e-05	0.000339	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—prostate cancer	3.48e-05	0.000317	CcSEcCtD
Meclofenamic acid—AKR1C3—Signaling Pathways—HIF1A—prostate cancer	7.29e-06	7.23e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HPGDS—prostate cancer	7.29e-06	7.22e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—INS—prostate cancer	7.27e-06	7.21e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	7.26e-06	7.19e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP2C19—prostate cancer	7.24e-06	7.18e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTO1—prostate cancer	7.24e-06	7.17e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HSD3B2—prostate cancer	7.24e-06	7.17e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NAT2—prostate cancer	7.24e-06	7.17e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MDM2—prostate cancer	7.22e-06	7.16e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CREBBP—prostate cancer	7.15e-06	7.09e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CREBBP—prostate cancer	7.12e-06	7.06e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERBB2—prostate cancer	7.12e-06	7.06e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—LEP—prostate cancer	7.12e-06	7.05e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTT1—prostate cancer	7.07e-06	7.01e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ACHE—prostate cancer	7.07e-06	7.01e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CAV1—prostate cancer	7.05e-06	6.99e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CB—prostate cancer	7.03e-06	6.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP2A6—prostate cancer	6.99e-06	6.93e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KDR—prostate cancer	6.97e-06	6.91e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—prostate cancer	6.96e-06	6.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.96e-06	6.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.96e-06	6.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PLCB2—prostate cancer	6.94e-06	6.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2C18—prostate cancer	6.94e-06	6.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—LRP2—prostate cancer	6.94e-06	6.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—P4HB—prostate cancer	6.81e-06	6.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKR1C3—prostate cancer	6.8e-06	6.74e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—prostate cancer	6.8e-06	6.73e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CD—prostate cancer	6.78e-06	6.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PRKACB—prostate cancer	6.76e-06	6.7e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CD—prostate cancer	6.75e-06	6.69e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP17A1—prostate cancer	6.69e-06	6.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	6.67e-06	6.61e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BAD—prostate cancer	6.63e-06	6.57e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC22A1—prostate cancer	6.62e-06	6.56e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.6e-06	6.54e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—prostate cancer	6.6e-06	6.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—B2M—prostate cancer	6.55e-06	6.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFBR1—prostate cancer	6.55e-06	6.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.54e-06	6.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SULT2A1—prostate cancer	6.45e-06	6.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	6.45e-06	6.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RPS19—prostate cancer	6.44e-06	6.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKR1C3—prostate cancer	6.44e-06	6.39e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APC—prostate cancer	6.42e-06	6.37e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CG—prostate cancer	6.42e-06	6.37e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKACB—prostate cancer	6.41e-06	6.35e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—NOS3—prostate cancer	6.4e-06	6.34e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOA2—prostate cancer	6.38e-06	6.32e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NOS3—prostate cancer	6.38e-06	6.32e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IRS1—prostate cancer	6.35e-06	6.29e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGF—prostate cancer	6.35e-06	6.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MED12—prostate cancer	6.35e-06	6.29e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GNG5—prostate cancer	6.3e-06	6.24e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PPP3CA—prostate cancer	6.25e-06	6.19e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CTNNB1—prostate cancer	6.23e-06	6.18e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GSK3B—prostate cancer	6.16e-06	6.11e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1A—prostate cancer	6.09e-06	6.03e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A5—prostate cancer	6.08e-06	6.03e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—INS—prostate cancer	6.08e-06	6.03e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—prostate cancer	6.07e-06	6.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA3—prostate cancer	6.07e-06	6.01e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKCZ—prostate cancer	6.04e-06	5.99e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.96e-06	5.91e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CREBBP—prostate cancer	5.96e-06	5.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP2E1—prostate cancer	5.94e-06	5.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALR—prostate cancer	5.94e-06	5.89e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CB—prostate cancer	5.91e-06	5.86e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CB—prostate cancer	5.89e-06	5.83e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1—prostate cancer	5.88e-06	5.83e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NQO1—prostate cancer	5.88e-06	5.82e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—prostate cancer	5.85e-06	5.8e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR4—prostate cancer	5.84e-06	5.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PARP1—prostate cancer	5.84e-06	5.79e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—prostate cancer	5.83e-06	5.78e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EP300—prostate cancer	5.79e-06	5.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TH—prostate cancer	5.79e-06	5.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HPGDS—prostate cancer	5.79e-06	5.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CALCA—prostate cancer	5.77e-06	5.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.75e-06	5.7e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2C19—prostate cancer	5.75e-06	5.7e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP3A4—prostate cancer	5.73e-06	5.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.7e-06	5.65e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAP2K1—prostate cancer	5.68e-06	5.63e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CD—prostate cancer	5.65e-06	5.6e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1B1—prostate cancer	5.63e-06	5.58e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SRC—prostate cancer	5.63e-06	5.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ACHE—prostate cancer	5.61e-06	5.56e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTT1—prostate cancer	5.61e-06	5.56e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SERPINE1—prostate cancer	5.58e-06	5.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2A6—prostate cancer	5.55e-06	5.5e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HSPA1A—prostate cancer	5.53e-06	5.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.53e-06	5.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GGT1—prostate cancer	5.46e-06	5.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.45e-06	5.4e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—STAT3—prostate cancer	5.43e-06	5.38e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FGF2—prostate cancer	5.41e-06	5.36e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKR1C3—prostate cancer	5.4e-06	5.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOA1—prostate cancer	5.37e-06	5.33e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PRKACB—prostate cancer	5.37e-06	5.32e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NOS3—prostate cancer	5.33e-06	5.28e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP17A1—prostate cancer	5.31e-06	5.27e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CASP9—prostate cancer	5.3e-06	5.26e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP19A1—prostate cancer	5.3e-06	5.25e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.24e-06	5.19e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JAK2—prostate cancer	5.18e-06	5.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRKCQ—prostate cancer	5.14e-06	5.09e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—RXRA—prostate cancer	5.11e-06	5.07e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—prostate cancer	5.11e-06	5.06e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—prostate cancer	5.09e-06	5.04e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA2—prostate cancer	5.06e-06	5.02e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MDM2—prostate cancer	5.06e-06	5.01e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—prostate cancer	5.05e-06	5e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFB1—prostate cancer	5.03e-06	4.99e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—prostate cancer	4.99e-06	4.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.97e-06	4.93e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—prostate cancer	4.94e-06	4.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—COMT—prostate cancer	4.92e-06	4.88e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CB—prostate cancer	4.92e-06	4.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTP1—prostate cancer	4.9e-06	4.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF10—prostate cancer	4.88e-06	4.84e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—EP300—prostate cancer	4.87e-06	4.83e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—EP300—prostate cancer	4.85e-06	4.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A5—prostate cancer	4.83e-06	4.79e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ITPR1—prostate cancer	4.82e-06	4.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.74e-06	4.7e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL8—prostate cancer	4.73e-06	4.69e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP2E1—prostate cancer	4.72e-06	4.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NQO1—prostate cancer	4.66e-06	4.62e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—prostate cancer	4.66e-06	4.62e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFBR2—prostate cancer	4.64e-06	4.6e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—prostate cancer	4.62e-06	4.58e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TH—prostate cancer	4.6e-06	4.56e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ITPR1—prostate cancer	4.57e-06	4.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.57e-06	4.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TYMS—prostate cancer	4.56e-06	4.52e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP3A4—prostate cancer	4.55e-06	4.51e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CASP3—prostate cancer	4.53e-06	4.49e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—prostate cancer	4.52e-06	4.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—prostate cancer	4.5e-06	4.46e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1B1—prostate cancer	4.47e-06	4.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—LPL—prostate cancer	4.42e-06	4.38e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—prostate cancer	4.41e-06	4.37e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNB1—prostate cancer	4.36e-06	4.33e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GGT1—prostate cancer	4.33e-06	4.29e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—prostate cancer	4.28e-06	4.25e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—prostate cancer	4.28e-06	4.24e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1A1—prostate cancer	4.27e-06	4.23e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOA1—prostate cancer	4.27e-06	4.23e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1A—prostate cancer	4.26e-06	4.22e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—prostate cancer	4.25e-06	4.22e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ERCC2—prostate cancer	4.23e-06	4.2e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP19A1—prostate cancer	4.2e-06	4.17e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LPL—prostate cancer	4.19e-06	4.15e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PDGFRB—prostate cancer	4.15e-06	4.12e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—RXRA—prostate cancer	4.06e-06	4.02e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EP300—prostate cancer	4.06e-06	4.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERCC2—prostate cancer	4.01e-06	3.98e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—prostate cancer	3.98e-06	3.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.95e-06	3.91e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SRC—prostate cancer	3.94e-06	3.91e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB3—prostate cancer	3.93e-06	3.89e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR2—prostate cancer	3.92e-06	3.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—COMT—prostate cancer	3.91e-06	3.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARA—prostate cancer	3.9e-06	3.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTP1—prostate cancer	3.89e-06	3.86e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—prostate cancer	3.84e-06	3.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ITPR1—prostate cancer	3.83e-06	3.79e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STAT3—prostate cancer	3.8e-06	3.77e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—prostate cancer	3.79e-06	3.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—prostate cancer	3.77e-06	3.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.76e-06	3.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—prostate cancer	3.76e-06	3.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CAV1—prostate cancer	3.67e-06	3.64e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TYMS—prostate cancer	3.62e-06	3.58e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—prostate cancer	3.6e-06	3.57e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HIF1A—prostate cancer	3.6e-06	3.57e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—prostate cancer	3.59e-06	3.56e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—prostate cancer	3.57e-06	3.54e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—prostate cancer	3.53e-06	3.5e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFB1—prostate cancer	3.53e-06	3.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—LPL—prostate cancer	3.51e-06	3.48e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.51e-06	3.48e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—prostate cancer	3.5e-06	3.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CAV1—prostate cancer	3.48e-06	3.45e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—prostate cancer	3.46e-06	3.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1A1—prostate cancer	3.39e-06	3.36e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ERCC2—prostate cancer	3.36e-06	3.33e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CG—prostate cancer	3.34e-06	3.31e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BAD—prostate cancer	3.27e-06	3.24e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—prostate cancer	3.27e-06	3.24e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APC—prostate cancer	3.17e-06	3.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—INS—prostate cancer	3.17e-06	3.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—prostate cancer	3.16e-06	3.13e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IRS1—prostate cancer	3.13e-06	3.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGF—prostate cancer	3.13e-06	3.11e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CREBBP—prostate cancer	3.1e-06	3.07e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARA—prostate cancer	3.1e-06	3.07e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GSK3B—prostate cancer	3.04e-06	3.01e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—prostate cancer	3e-06	2.97e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—INS—prostate cancer	3e-06	2.97e-05	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—prostate cancer	2.94e-06	2.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CD—prostate cancer	2.94e-06	2.91e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CREBBP—prostate cancer	2.94e-06	2.91e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—prostate cancer	2.93e-06	2.91e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CAV1—prostate cancer	2.91e-06	2.89e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—prostate cancer	2.9e-06	2.88e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAP2K1—prostate cancer	2.8e-06	2.78e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CD—prostate cancer	2.79e-06	2.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.78e-06	2.76e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NOS3—prostate cancer	2.78e-06	2.75e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SERPINE1—prostate cancer	2.76e-06	2.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGF2—prostate cancer	2.67e-06	2.64e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—prostate cancer	2.66e-06	2.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CG—prostate cancer	2.65e-06	2.63e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS3—prostate cancer	2.63e-06	2.61e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CB—prostate cancer	2.56e-06	2.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JAK2—prostate cancer	2.56e-06	2.53e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—prostate cancer	2.54e-06	2.52e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—INS—prostate cancer	2.51e-06	2.49e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MDM2—prostate cancer	2.5e-06	2.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CREBBP—prostate cancer	2.46e-06	2.44e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—prostate cancer	2.46e-06	2.44e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—prostate cancer	2.45e-06	2.43e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CB—prostate cancer	2.43e-06	2.41e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CD—prostate cancer	2.33e-06	2.31e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—prostate cancer	2.28e-06	2.26e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—prostate cancer	2.21e-06	2.19e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NOS3—prostate cancer	2.2e-06	2.18e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CTNNB1—prostate cancer	2.15e-06	2.13e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—EP300—prostate cancer	2.11e-06	2.09e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1A—prostate cancer	2.1e-06	2.08e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—prostate cancer	2.1e-06	2.08e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CB—prostate cancer	2.03e-06	2.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EP300—prostate cancer	2e-06	1.98e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SRC—prostate cancer	1.95e-06	1.93e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT3—prostate cancer	1.88e-06	1.86e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—prostate cancer	1.76e-06	1.74e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—prostate cancer	1.74e-06	1.73e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFB1—prostate cancer	1.74e-06	1.72e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—prostate cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—EP300—prostate cancer	1.68e-06	1.66e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—prostate cancer	1.61e-06	1.6e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—prostate cancer	1.56e-06	1.55e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—prostate cancer	1.48e-06	1.47e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—prostate cancer	1.31e-06	1.3e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—prostate cancer	1.28e-06	1.26e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—prostate cancer	1.24e-06	1.23e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—prostate cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—prostate cancer	1.01e-06	1e-05	CbGpPWpGaD
